Cargando…
The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD
Purpose: To investigate whether the coronavirus disease 2019 (COVID-19) pandemic-associated postponement in care had effects on the baseline clinical presentation of patients with newly diagnosed treatment-naïve exudative neovascular age-related macular degeneration (AMD). Methods: We included the f...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003286/ https://www.ncbi.nlm.nih.gov/pubmed/33803808 http://dx.doi.org/10.3390/jcm10061265 |
_version_ | 1783671654081101824 |
---|---|
author | Borrelli, Enrico Battista, Marco Vella, Giovanna Grosso, Domenico Sacconi, Riccardo Querques, Lea Zucchiatti, Ilaria Prascina, Francesco Bandello, Francesco Querques, Giuseppe |
author_facet | Borrelli, Enrico Battista, Marco Vella, Giovanna Grosso, Domenico Sacconi, Riccardo Querques, Lea Zucchiatti, Ilaria Prascina, Francesco Bandello, Francesco Querques, Giuseppe |
author_sort | Borrelli, Enrico |
collection | PubMed |
description | Purpose: To investigate whether the coronavirus disease 2019 (COVID-19) pandemic-associated postponement in care had effects on the baseline clinical presentation of patients with newly diagnosed treatment-naïve exudative neovascular age-related macular degeneration (AMD). Methods: We included the first 50 consecutive patients referred within the COVID-19 pandemic with a diagnosis of treatment-naïve exudative neovascular AMD. Two groups of fifty consecutive patients with newly diagnosed neovascular exudative AMD presenting in 2018 and 2019 (control periods) were also included for comparisons. Results: Baseline visual acuity was statistically worse in patients referred during the COVID-19 pandemic period (0.87 ± 0.51 logarithm of the minimum angle of resolution (LogMAR)) as compared with both the “2019” (0.67 ± 0.48 LogMAR, p = 0.001) and “2018” (0.69 ± 0.54 LogMAR, p = 0.012) control periods. Data on the visual function after a loading dose of anti-vascular endothelial growth factor (VEGF) was available in a subset of patients (43 subjects in 2020, 45 in 2019 and 46 in 2018, respectively). Mean ± SD best corrected visual acuity (BCVA) at the 1-month follow-up visit after the third anti-VEGF injection was still worse in patients referred during the COVID-19 pandemic (0.82 ± 0.66 LogMAR) as compared with both the “2019” (0.60 ± 0.45 LogMAR, p = 0.021) and “2018” (0.55 ± 0.53 LogMAR, p = 0.001) control periods. On structural optical coherence tomography (OCT), the maximum subretinal hyperreflective material (SHRM) height and width were significantly greater in the COVID-19 pandemic patients. Conclusions: We demonstrated that patients with newly diagnosed treatment-naïve exudative neovascular AMD referred during the COVID-19 pandemic had worse clinical characteristics at presentation and short-term visual outcomes. |
format | Online Article Text |
id | pubmed-8003286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80032862021-03-28 The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD Borrelli, Enrico Battista, Marco Vella, Giovanna Grosso, Domenico Sacconi, Riccardo Querques, Lea Zucchiatti, Ilaria Prascina, Francesco Bandello, Francesco Querques, Giuseppe J Clin Med Article Purpose: To investigate whether the coronavirus disease 2019 (COVID-19) pandemic-associated postponement in care had effects on the baseline clinical presentation of patients with newly diagnosed treatment-naïve exudative neovascular age-related macular degeneration (AMD). Methods: We included the first 50 consecutive patients referred within the COVID-19 pandemic with a diagnosis of treatment-naïve exudative neovascular AMD. Two groups of fifty consecutive patients with newly diagnosed neovascular exudative AMD presenting in 2018 and 2019 (control periods) were also included for comparisons. Results: Baseline visual acuity was statistically worse in patients referred during the COVID-19 pandemic period (0.87 ± 0.51 logarithm of the minimum angle of resolution (LogMAR)) as compared with both the “2019” (0.67 ± 0.48 LogMAR, p = 0.001) and “2018” (0.69 ± 0.54 LogMAR, p = 0.012) control periods. Data on the visual function after a loading dose of anti-vascular endothelial growth factor (VEGF) was available in a subset of patients (43 subjects in 2020, 45 in 2019 and 46 in 2018, respectively). Mean ± SD best corrected visual acuity (BCVA) at the 1-month follow-up visit after the third anti-VEGF injection was still worse in patients referred during the COVID-19 pandemic (0.82 ± 0.66 LogMAR) as compared with both the “2019” (0.60 ± 0.45 LogMAR, p = 0.021) and “2018” (0.55 ± 0.53 LogMAR, p = 0.001) control periods. On structural optical coherence tomography (OCT), the maximum subretinal hyperreflective material (SHRM) height and width were significantly greater in the COVID-19 pandemic patients. Conclusions: We demonstrated that patients with newly diagnosed treatment-naïve exudative neovascular AMD referred during the COVID-19 pandemic had worse clinical characteristics at presentation and short-term visual outcomes. MDPI 2021-03-18 /pmc/articles/PMC8003286/ /pubmed/33803808 http://dx.doi.org/10.3390/jcm10061265 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Borrelli, Enrico Battista, Marco Vella, Giovanna Grosso, Domenico Sacconi, Riccardo Querques, Lea Zucchiatti, Ilaria Prascina, Francesco Bandello, Francesco Querques, Giuseppe The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD |
title | The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD |
title_full | The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD |
title_fullStr | The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD |
title_full_unstemmed | The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD |
title_short | The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD |
title_sort | covid-19 pandemic has had negative effects on baseline clinical presentation and outcomes of patients with newly diagnosed treatment-naïve exudative amd |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003286/ https://www.ncbi.nlm.nih.gov/pubmed/33803808 http://dx.doi.org/10.3390/jcm10061265 |
work_keys_str_mv | AT borrellienrico thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT battistamarco thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT vellagiovanna thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT grossodomenico thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT sacconiriccardo thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT querqueslea thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT zucchiattiilaria thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT prascinafrancesco thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT bandellofrancesco thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT querquesgiuseppe thecovid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT borrellienrico covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT battistamarco covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT vellagiovanna covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT grossodomenico covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT sacconiriccardo covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT querqueslea covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT zucchiattiilaria covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT prascinafrancesco covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT bandellofrancesco covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd AT querquesgiuseppe covid19pandemichashadnegativeeffectsonbaselineclinicalpresentationandoutcomesofpatientswithnewlydiagnosedtreatmentnaiveexudativeamd |